Key result
Stenting with half (disarticulated) Palmaz-Schatz coronary stents managed with aspirin alone resulted in no acute or subacute stent thrombosis in eight consecutive patients.
Why the study?
Does stenting with half Palmaz-Schatz coronary stents managed with aspirin alone prevent acute or subacute stent thrombosis in patients undergoing coronary angioplasty?
Case Report (n=8)
Does stenting with half Palmaz-Schatz coronary stents managed with aspirin alone prevent acute or subacute stent thrombosis in patients undergoing coronary angioplasty?
Stenting with half Palmaz-Schatz stents managed with aspirin alone appears feasible without acute or subacute stent thrombosis in a small initial case series.
May support aspirin-only half-stent use in small series; leaves open need for larger trials before adoption.
Stents are useful bail-out devices in coronary angioplasty. They are also used electively for situations associated with poor angioplasty results (e.g., restenotic lesions, venous grafts) and may reduce restenosis rates. However, the significant incidence of stent thrombosis necessitated aggressive anticoagulation with associated hemorrhagic complications. This remains a major limitation of stenting. We present our experience of stenting with half (disarticulated) Palmaz-Schatz coronary stents in eight consecutive patients, managed with aspirin alone. No patient experienced acute or subacute stent thrombosis.
No takes yet. Share an insight, caveat, or question.
Mehan et al. (1995) conducted a case report in Coronary angioplasty requiring stenting (n=8). Half (disarticulated) Palmaz-Schatz coronary stents managed with aspirin alone was evaluated on Acute or subacute stent thrombosis. Stenting with half (disarticulated) Palmaz-Schatz coronary stents managed with aspirin alone resulted in no acute or subacute stent thrombosis in eight consecutive patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: